Systemic Juvenile Idiopathic Arthritis - Epidemiology Forecast to 2027

Systemic Juvenile Idiopathic Arthritis - Epidemiology Forecast to 2027

Category

Pharmaceuticals

Published Date

1st Feb 2018

Pages

50

Choose License

Final Price

DelveInsight's "Systemic Juvenile Idiopathic Arthritis (SJIA) - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Systemic Juvenile Idiopathic Arthritis (SJIA) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2027

Systemic Juvenile Idiopathic Arthritis (SJIA) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Systemic Juvenile Idiopathic Arthritis (SJIA) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Systemic Juvenile Idiopathic Arthritis (SJIA) outlook. It also includes the explanation of changing trends of epidemiology outlining the Systemic Juvenile Idiopathic Arthritis (SJIA) scenario.

Systemic Juvenile Idiopathic Arthritis (SJIA) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Systemic Juvenile Idiopathic Arthritis (SJIA) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Systemic Juvenile Idiopathic Arthritis (SJIA) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Systemic Juvenile Idiopathic Arthritis (SJIA) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Systemic Juvenile Idiopathic Arthritis (SJIA)

Key assessments
• Patient Segmentation in Systemic Juvenile Idiopathic Arthritis (SJIA)
• Systemic Juvenile Idiopathic Arthritis (SJIA) Risk & Burden
• Factors driving growth in a specific Systemic Juvenile Idiopathic Arthritis (SJIA) patient population
1. Report Introduction
2. Systemic Juvenile Idiopathic Arthritis (SJIA) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Systemic Juvenile Idiopathic Arthritis (SJIA) in 2017
2.2. Patient Share Distribution of Systemic Juvenile Idiopathic Arthritis (SJIA) in 2027
3. Disease Background and Overview: Systemic Juvenile Idiopathic Arthritis (SJIA)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Systemic Juvenile Idiopathic Arthritis (SJIA) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Systemic Juvenile Idiopathic Arthritis (SJIA) in 7MM – By Countries
5. Epidemiology of Systemic Juvenile Idiopathic Arthritis (SJIA) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA)
5.1.3. Sub-Type Specific cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) *
5.1.4. Sex- Specific Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) *
5.1.5. Diagnosed Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA)
5.4.3. Sub-Type Specific cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) *
5.4.4. Sex- Specific Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) *
5.4.5. Diagnosed Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA)
5.5.3. Sub-Type Specific cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) *
5.5.4. Sex- Specific Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) *
5.5.5. Diagnosed Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA)
5.6.3. Sub-Type Specific cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) *
5.6.4. Sex- Specific Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) *
5.6.5. Diagnosed Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA)
5.7.3. Sub-Type Specific cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) *
5.7.4. Sex- Specific Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) *
5.7.5. Diagnosed Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA)
5.8.3. Sub-Type Specific cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) *
5.8.4. Sex- Specific Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) *
5.8.5. Diagnosed Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA)
5.9.3. Sub-Type Specific cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) *
5.9.4. Sex- Specific Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) *
5.9.5. Diagnosed Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA)
6. Unmet Needs of the Systemic Juvenile Idiopathic Arthritis (SJIA)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific
Table 1: Total Prevalent/Incident Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in 7MM
Table 2: Total Prevalent/Incident Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in United States (2016-2027)
Table 4: Sub-Type Specific cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in United States (2016-2027)*
Table 5: Sex- Specific Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in United States (2016-2027)*
Table 6: Diagnosed Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in United States (2016-2027)
Table 7: Prevalent/Incident Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in Germany (2016-2027)
Table 8: Sub-Type Specific cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in Germany (2016-2027) *
Table 9: Sex- Specific Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in Germany (2016-2027) *
Table 10: Diagnosed Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in Germany (2016-2027)
Table 11: Prevalent/Incident Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in France (2016-2027)
Table 12: Sub-Type Specific cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in France (2016-2027) *
Table 13: Sex- Specific Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in France (2016-2027) *
Table 14: Diagnosed Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in France (2016-2027)
Table 15: Prevalent/Incident Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in Italy (2016-2027)
Table 16: Sub-Type Specific cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in Italy (2016-2027) *
Table 17: Sex- Specific Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in Italy (2016-2027) *
Table 18: Diagnosed Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in Italy (2016-2027)
Table 19: Prevalent/Incident Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in Spain (2016-2027)
Table 20: Sub-Type Specific cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in Spain (2016-2027) *
Table 21: Sex- Specific Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in Spain (2016-2027) *
Table 22: Diagnosed Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in Spain (2016-2027)
Table 23: Prevalent/Incident Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in UK (2016-2027)
Table 24: Sub-Type Specific cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in UK (2016-2027) *
Table 25: Sex- Specific Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in UK (2016-2027) *
Table 26: Diagnosed Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in UK (2016-2027)
Table 27: Prevalent/Incident Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in Japan (2016-2027)
Table 28: Sub-Type Specific cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in Japan (2016-2027) *
Table 29: Sex- Specific Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in Japan (2016-2027) *
Table 30: Diagnosed Cases of the Systemic Juvenile Idiopathic Arthritis (SJIA) in Japan (2016-2027)

Get Free Sample

You can get a FREE sample of any report. Just click the "Free Sample" link.

Explore Latest Reports

If you have any special requirement or looking for more discounts, Kindly contact our sales team

Contact Us